London +4420 814 42225
Moscow +7495 543 9194
Kiev +38044 599 2950
info@mrcplast.com

Our Clients

Order Informer

 
Home > News >
 

Bayer and Monsanto merger receives CFIUS approval

December 04/2017

MOSCOW (MRC) -- Bayer and Monsanto said that the Committee on Foreign Investment in the United States or "CFIUS" has completed its review of the proposed merger, and has concluded that there are no unresolved national security concerns with respect to the transaction, as per Bayer's press release.

The acquisition is subject to customary closing conditions, including receipt of required regulatory approvals.

Bayer and Monsanto will continue to cooperate with the authorities in order to complete the transaction in early 2018.

As MRC reported before, in summer 2016, Bayer shareholders voiced skepticism about a Monsanto acquisition. A survey of Bayer shareholders in June found widespread dissatisfaction with the proposed deal, and one Bayer investor has called for a shareholder vote on it.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen.


mrcplast.com
Author:Margaret Volkova
Tags:fertilizers, Bayer, Germany, USA.
Category:General News
|
| More

Leave a comment

MRC help

 


 All News   News subscribe